Upexi Inc
UPXI
查看详细走势图
1.140USD
+0.050+4.59%
收盘 02/06, 16:00（美东）报价延迟15分钟
67.14M总市值
0.04市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+4.59%
5天
-35.96%
1月
-48.88%
6月
-81.13%
今年开始到现在
-32.14%
1年
-70.92%
查看详细走势图
TradingKey Upexi Inc股票评分
单位: USD 更新时间: 2026-02-06操作建议
Upexi Inc当前公司基本面数据相对稳定，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在软件与IT服务行业排名194/482位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价7.00。中期看，股价处于下降通道。近一个月，市场表现非常差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Upexi Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Upexi Inc亮点
亮点风险
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
业绩增长期
公司处于发展阶段，最新年度总收入15.81M美元
估值高估
公司最新PE估值0.04，处于3年历史高位
机构减仓
最新机构持股14.36M股，环比减少38.46%
先锋集团持仓
明星投资者先锋集团持仓，最新持仓市值710.74K
分析师目标
根据
2
位分析师
买入
评级
7.000
目标均价
+514.04%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Upexi Inc简介
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
公司代码UPXI
公司Upexi Inc
CEOMarshall (Allan)
网址https://upexi.com/
相关品种
